Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|April 3, 2017
Host-guest kinetic interactions between HP-β-cyclodextrin and drugs for prediction of bitter taste maskingZhen Guo, Fei Wu, Vikramjeet Singh, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 30, 2013
NCAM polysialylation during adherence transitions: live cell monitoring using an antibody-mimetic EGFP-endosialidase and the viability dye DRAQ7Paul J Smith, Emeline Furon, Marie Wiltshire, et al.
Carbohydrate Polymers|March 6, 2021
An assay for quantitative analysis of polysialic acid expression in cancer cellsXiaoxiao Guo, Sara M Elkashef, Anjana Patel, et al.
The Analyst|May 16, 2020
An efficient assay for identification and quantitative evaluation of potential polysialyltransferase inhibitorsXiaoxiao Guo, Jodie R Malcolm, Marrwa M Ali, et al.
Molecular Pharmaceutics|March 20, 2014
Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicityJason H Gill, Paul M Loadman, Steven D Shnyder, et al.
Cancer Gene Therapy|December 19, 2002
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4NHelen O McCarthy, Anita Yakkundi, Verna McErlane, et al.
Chemical Communications (Cambridge, England)|October 18, 2011
Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activityKlaus Pors, Paul M Loadman, Steven D Shnyder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxinsSandra Travica, Klaus Pors, Paul M Loadman, et al.
Chemmedchem|May 8, 2016
Rational Development of Novel Activity Probes for the Analysis of Human Cytochromes P450Jonathan D Sellars, Mark Skipsey, Sadr-Ul-Shaheed, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 14, 2006
Spectral analysis of the DNA targeting bisalkylaminoanthraquinone DRAQ5 in intact living cellsKerenza L Njoh, Laurence H Patterson, Mire Zloh, et al.
Pageof 6